Your browser doesn't support javascript.
loading
Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma.
Shen, Fang-Fang; Pan, Ying; Yang, Hai-Jun; Li, Jun-Kuo; Zhao, Fang; Su, Jing-Fen; Li, Yan-Yan; Tian, Lin-Qiang; Yu, Pan-Ting; Cao, Yan-Tian; Zhang, Yao-Wen; Zhou, Fu-You.
Affiliation
  • Shen FF; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Pan Y; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Yang HJ; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
  • Li JK; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
  • Zhao F; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
  • Su JF; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
  • Li YY; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Tian LQ; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Yu PT; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Cao YT; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
  • Zhang YW; Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
  • Zhou FY; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Onco Targets Ther ; 12: 4755-4763, 2019.
Article in En | MEDLINE | ID: mdl-31417276
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Onco Targets Ther Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Onco Targets Ther Year: 2019 Document type: Article